1. Home
  2. ANVS vs BODI Comparison

ANVS vs BODI Comparison

Compare ANVS & BODI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANVS
  • BODI
  • Stock Information
  • Founded
  • ANVS 2008
  • BODI 1998
  • Country
  • ANVS United States
  • BODI United States
  • Employees
  • ANVS N/A
  • BODI N/A
  • Industry
  • ANVS Biotechnology: Pharmaceutical Preparations
  • BODI Industrial Machinery/Components
  • Sector
  • ANVS Health Care
  • BODI Industrials
  • Exchange
  • ANVS Nasdaq
  • BODI Nasdaq
  • Market Cap
  • ANVS 24.2M
  • BODI 28.3M
  • IPO Year
  • ANVS 2020
  • BODI N/A
  • Fundamental
  • Price
  • ANVS $1.53
  • BODI $4.95
  • Analyst Decision
  • ANVS Strong Buy
  • BODI Strong Buy
  • Analyst Count
  • ANVS 4
  • BODI 3
  • Target Price
  • ANVS $40.67
  • BODI $10.67
  • AVG Volume (30 Days)
  • ANVS 460.8K
  • BODI 24.8K
  • Earning Date
  • ANVS 05-20-2025
  • BODI 05-14-2025
  • Dividend Yield
  • ANVS N/A
  • BODI N/A
  • EPS Growth
  • ANVS N/A
  • BODI N/A
  • EPS
  • ANVS N/A
  • BODI N/A
  • Revenue
  • ANVS N/A
  • BODI $418,796,000.00
  • Revenue This Year
  • ANVS N/A
  • BODI N/A
  • Revenue Next Year
  • ANVS N/A
  • BODI N/A
  • P/E Ratio
  • ANVS N/A
  • BODI N/A
  • Revenue Growth
  • ANVS N/A
  • BODI N/A
  • 52 Week Low
  • ANVS $1.11
  • BODI $3.70
  • 52 Week High
  • ANVS $17.88
  • BODI $9.90
  • Technical
  • Relative Strength Index (RSI)
  • ANVS 49.17
  • BODI 50.94
  • Support Level
  • ANVS $1.42
  • BODI $3.79
  • Resistance Level
  • ANVS $1.75
  • BODI $5.46
  • Average True Range (ATR)
  • ANVS 0.16
  • BODI 0.44
  • MACD
  • ANVS 0.03
  • BODI 0.21
  • Stochastic Oscillator
  • ANVS 43.59
  • BODI 71.02

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

About BODI The Beachbody Company Inc. Class A Common Stock

The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in one operating segment. Majority of revenue is through Digital.

Share on Social Networks: